findmyKOL

Richard Eiferman, MD

Basic profile

University of Louisville

ORCIDNone on fileNPI
RegionLouisville, KY · SoutheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2013Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Richard Eiferman is an Ophthalmology physician affiliated with University of Louisville. OpenAlex indexes 107 publications with 2,429 citations (h-index 26).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
107publications

Distinct works indexed by OpenAlex.

2,429citations

Total citations across indexed works.

26h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
15companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6400 Dutchmans Parkway
Ste 220
Louisville, KY 40205

Telephone

502-895-4200

Registry record last updated 26 May 2011.

View the NPPES registry record

Industry payments

15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    72.5%
    Corticosteroid44.3%
    Prednisolone Acetate65%Fluorometholone35%
    Part D125 patients
    alpha-Adrenergic Agonist7.2%
    Brimonidine Tartrate-Timolol43%Brimonidine Tartrate32%Combigan26%
    Part D<11 patients

    + 6 more classes in this area

  • Cancer & immunology

    10.6%
    Calcineurin inhibitor10.6%
    Restasis86%Cyclosporine14%
    Part D<11 patients
  • Anti-infectives

    10.4%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor6.4%
    Valacyclovir100%
    Part D14 patients
    Tetracycline-class Drug2%
    Doxycycline Hyclate100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)2.9% facility · 97.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”